Mylan Surges After Quickly Settling With DoJ Over EpiPen Medicaid Rebates
- Saturday, October 8, 2016, 10:20
- Market
- Add a comment
Mylan will pay $465 million to settle with the Department of Justice over its classification of EpiPen in Medicaid rebate programs.
http://www.forbes.com/sites/antoinegara/2016/10/08/mylan-surges-after-quickly-settling-with-doj-over-epipen-medicaid-rebates/
About the Author
admin123 has written 23412 stories on this site.
